WebBiovisics Medical. We have developed the first [to be FDA approved] medical device to treat blinding retinal diseases such as macular degeneration and retinitis pigmentos. … WebBiovisics Medical: USA: n/a: Founded in 2024, Biovisics Medical is pioneering bioelectronic therapies for human degenerative retinal diseases. Juice in the City, Inc: USA: Private: n/a. Virimodo: USA: Private: Virimodo is a NYC-based carbon reduction intelligence company committed to reducing greenhouse gases in cities globally. ...
Computational modeling of posteroanterior lumbar traction by
WebApr 13, 1994 · The present invention relates to a kind of multifunctional therapeutic instrument for eye diseases that combines with electric massage and medicine ion importing, it is made up of the modulator... inability to stay hydrated
Patents Assigned to Biovisics, Inc. - Justia Patents Search
WebBIOVISICS - Trademark Details. Status: 733 - Fourth Extension - Granted. Serial Number. 88322495. Word Mark. BIOVISICS. Status. 733 - Fourth Extension - Granted. Status Date. 2024-08-11. Filing Date. 2024-03-01. Mark Drawing. 4000 - Standard character mark Typeset. Published for Opposition Date. 2024-06-18. WebBiovisics Medical has 3 current employee profiles, including Chief Commercial Officer Paul Rockley. Paul Rockley Chief Commercial Officer John Alexander Chief Operating Officer/Chief Financial Officer Jim Chiapetta Co-Founder CEO Board Member and Advisor Profiles Number of Board Member and Advisor Profiles 1 WebBiovisics uses targeted micro-current energy to address the Dry form of Macular Degeneration (AMD) and Retinitis Pigmentosa (RP). Biovisics has completed two human Pilot clinical trials for RP and AMD that demonstrated safety, stability and improvements in visual acuity, fields, contrast sensitivity and quality of life. inability to stand for long periods of time